1. Pink Sheet
  2. >>Legal & IP

Medicare Drug Pricing In Court: Judge Praises ‘Zealous Advocacy’ Of Attorneys In First Hearing On IRA

 
• By Brenda Sandburg

DOJ and Chamber of Commerce attorneys argue over whether Chamber has standing to sue and whether AbbVie has suffered harm meriting a preliminary injunction to halt the program. With Medicare’s Oct. 2 deadline looming, Judge Newman said he would issue a decision ‘as quickly as we can.’

Chamber of Commerce hearing on IRA 09 15 2023
DOJ brought two attorneys to the Zoom fight. • Source: Screenshot

Judge Michael Newman asked no questions during the first court hearing on the Inflation Reduction Act’s Medicare price negotiation program but expressed appreciation for the arguments of the attorneys representing the US Chamber of Commerce and the US government, which included discussion of what the CEO of Novo Nordisk A/S meant in comments about the program’s impact on his company’s drugs.

The Chamber is seeking a preliminary injunction to halt the program while its suit against the US Department of Health and Human Services proceeds, and the government is requesting that the complaint be dismissed

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legal & IP

More from Pink Sheet

EU Shaping Biotech Act To Unleash SME Potential

 
• By Neena Brizmohun

European companies, in particular small and midsize enterprises, spin-offs and start-ups have a hard time expanding within the single market “because of a complex regulatory framework that is perceived as slow and burdensome,” according to the European Commission.

New EU Filings

 
• By Neena Brizmohun

Brensocatib, Insmed's investigational treatment for non-cystic fibrosis bronchiectasis, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.

‘Tectonic’ Arkansas PBM Legislation May Upend Industry

 
• By Tim Casey

Industry will fight hard to prevent other states or the federal government from adopting measures similar to Arkansas' law preventing PBMs from owning pharmacies.